Information
Learning Objective 1
Recognize changes in the brain tumor microenvironment associated with hyperexcitability and identify several associated opportunities for novel targeted treatments to reduce seizure risk
Learning Objective 2
Identify neuroimaging biomarkers associated with increased seizure risk in tumor-related epilepsy
Learning Objective 3
Describe approaches to assess hyperexcitability at the brain-tumor interface in patients with tumor-related epilepsy
Target Audience
CliniciansFellows/TraineesAdvanced Practice Providers (APPs)NursesScientists/Researchers
Career Stage
Early Career (typically 0-5 years from completion of training)Mid-Career (typically 6-15 years from completion of trainingSenior (typically >15 years from completion of training)
Demographics
ClinicalYoung ProfessionalsResearchFirst-time Attendee
Session ID
TUMORSIG26
Presentation Id
3452266
Event ID
24056
Session Type
Session

